Stock Events

Stock Events

Agios Pharmaceuticals (8AP.F) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-1.6

-1.52

-1.43

-1.35

Details

Expected EPS

-1.48435601325

Actual EPS

-1.5662075

Surprise EPS

-0.08

Surprise Percent

+5.51%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.5662075 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.